Major strides for the company on two fronts – psychedelic therapies and treatment-resistant depression (TRD) – came in the ...

Scientists at the University of Pittsburgh have tested a broadly neutralizing antibody (bnAb) that binds the stem of a protein against H5N1 avian influenza, which prevented severe disease in nonhuman ...

Whether Robert F. Kennedy Jr. (RFK) advances in his quest to become the top health care voice in the Trump administration could come down to one vote – that of Sen. Bill Cassidy. The Louisiana doctor ...

Implanted patches of iPS cell-derived heart muscle integrated with heart tissue in a primate model of heart failure, and in ...

Harness Therapeutics Ltd. has raised fresh financing to further develop its technology for upregulating the translation of ...

Alterity Therapeutics Ltd. reported positive top-line phase II results for lead candidate ATH-434 for treating multiple ...

With multiple large M&A deals already announced in January, CEOs of major med-tech companies outlining acquisition plans for ...

Researchers from Fundación Jiménez Díaz and affiliated organizations have published data from a study that aimed to identify ...

Shares of Tectonic Therapeutic Inc. (NASDAQ:TECX) closed Jan. 30 at $54.84, up $29.12, or 113%, on what Leerink analyst David ...

An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...

California Institute for Regenerative Medicine (CIRM) has awarded a $5.8 million translational research grant to a scientist at the University of California, Los Angeles (UCLA) to further support the ...

Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. has described histone acetyltransferase KAT6A (monocytic leukemia zinc finger protein; MOZ; MYST-3) and/or KAT6B (MOZ2; MYST-4) ...